Is Ibogaine Legal in Mexico?

What the law says, and what it does not say

Mexico’s General Health Law classifies psychotropic substances into five groups under Article 245. Ibogaine appears in none of them.

Nothing else in Mexican drug law names it either. Article 193 of the Federal Penal Code defines a narcotic by reference to the General Health Law and to the treaties binding on Mexico, and ibogaine is in neither. There is no prohibition to breach, and consequently no drug offence in possessing, administering or importing it for use within the country.

Why the clinics are there

The map of ibogaine treatment is drawn almost entirely by this one fact, and Costa Rica is the only other country where the same gap produced the same sector.

The United States prohibits ibogaine and generates the largest demand for it. Mexico does not prohibit it and shares a land border with that demand. Tijuana, Cancún and Rosarito are the recurring destinations, and the sector that grew up around them exists because of a gap in a schedule rather than because of a medical decision by anyone.

That origin matters, because it explains what the sector is missing.

What unscheduled does not give you

No approval. COFEPRIS, Mexico’s health regulator, has authorised no ibogaine product for any indication. Nobody has demonstrated safety or efficacy to a Mexican regulator, because nobody has been required to.

No hospital standard. Nothing requires a facility administering ibogaine to be a hospital, because no rule attaches to the substance. What does attach is the regime for addiction treatment: Articles 47 and 200 Bis of the General Health Law require an aviso de funcionamiento and a named responsable sanitario, and NOM-028-SSA2-2009 requires a residential facility to register with CONADIC and sets conditions for admission, staffing and records. None of it was written with ibogaine in mind and none of it requires cardiac screening. Some clinics have physicians, cardiac monitoring and a defibrillator in the room. Others have a room.

No inspection aimed at this. COFEPRIS inspects health establishments against the rules for the category they registered in. There is no rule about ibogaine to inspect against, and no cardiac standard the substance triggers.

What to ask a Mexican provider

Nothing in Mexican law obliges a clinic to answer any of this, which is exactly why the answers are informative. A provider who cannot answer the first three has told you what you needed to know.

• Which authority licenses this facility, under what name, and can you see the aviso de funcionamiento?
• Who is the responsable sanitario named on it?
• Is the facility registered with CONADIC as a residential addiction programme under NOM-028-SSA2-2009?
• Is a physician present for the whole session, and in what discipline are they registered?
• Is an ECG performed before administration, and who reads it?
• Is cardiac rhythm monitored continuously during the session, by whom, and on what equipment?
• What is the written protocol if an arrhythmia starts, and what is on site to manage it?
• How far is the nearest hospital with a cardiac unit, and how long does the transfer take?
• Is the substance pharmaceutical-grade ibogaine hydrochloride or root bark, and where did it come from?

The treatment section carries the full list and the answers that should end the conversation.

The last two are real, and neither of them mentions ibogaine or a heart.

The border is a separate question

Being lawfully treated in Mexico says nothing about what happens when you leave.

Importing ibogaine into the United States is a federal offence, and the same is true of most countries with a schedule entry. This applies to a small quantity carried for personal use after a session, which is a common and consequential misunderstanding. The lawful part of the trip ends at the border.

There is also the practical matter of the days after. Ibogaine’s active metabolite, noribogaine, persists for days, and the cardiac window does not close when the visions do. Flying home the following morning is a decision worth taking with a clinician rather than a travel agent.

What would change Mexico’s position

Mexico could schedule ibogaine, and the sector would move. It could also regulate the clinics without scheduling the substance, which is the outcome harm-reduction advocates generally argue for: an approval pathway, a minimum standard for cardiac screening, and an inspection regime.

Neither has happened. Until one does, the answer to “is it legal in Mexico” is yes in the narrow sense that matters least, and the questions that matter more are all about the provider rather than the law.

See the status by country table for the full picture, and the federal position for why the demand exists.